Background: Cardiovascular medicine is growing because prevalence of metabolic diseases is on the increase world-wide; hence regular review of what is known or new will remain a benefit to medical scientists. Objective: This ‘preventive cardiovascular medicine’ workshop is a brief review ‘as a professional group’ knowledge, attitude and practice on: (1) assessing responsiveness of antiplatelet therapy, (2) CVD screening and (3) smoking cessation impact on vasculopathy. Significance: This will inform our behavioural change wheel i.e. capability, motivation and opportunity. There has been a series of studies exploring the use of extrapolations from blood results to determine blood viscosity. The significance to the three themes of laboratory testing are (1) Responsiveness of patients to antiplatelet therapy, (2) for pathology-based evidence of asymptomatic vasculopathy being a CVD risk factor, and (3) on smokers with potential to give the smoking network another tool additional to the smokelyzer to support people to quit smoking.
|Publication status||Published - 2016|
|Event||SW NSW AIMS Conference 2016 - Orange, Australia|
Duration: 01 Jan 2016 → …
|Conference||SW NSW AIMS Conference 2016|
|Period||01/01/16 → …|